Back to Search Start Over

Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? Does bortezomib inform our understanding of the immunology underlying neuromyelitis optica spectrum disorders?

Authors :
Taylor, J
Irani, SR
Publication Year :
2017
Publisher :
American Medical Association), 2017.

Details

Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..1206feea1edf2b0192a420634fe162f1
Full Text :
https://doi.org/10.1001/jamaneurol.2017.3447